Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Washington University

NCT04353388 — Completed, 1139 participants, Beckman Coulter, Inc.

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Post Market Observational Study of ESId (MDW Hematology Parameter) for Early Sepsis Detection in the Emergency Department (US Hospitals) and Potential Reduction in Time to Antibiotics - Washington University

RegistryNCT04353388
StatusCompleted
Study typeObservational
Enrollment1139 (Actual)
SponsorBeckman Coulter, Inc. (Industry)
ConditionsSepsis, Adult Disease, Severe Sepsis, Emergency Department
InterventionsCBC-DIFF Monocyte Volume Width Distribution (MDW) (Diagnostic test)
Datesstart 2020-02-03, primary completion 2020-07-17, completion 2020-07-17, first posted 2020-04-20, last updated 2021-03-17
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Sepsis All trials for Adult Disease All trials of CBC-DIFF Monocyte Volume Width Distribution (MDW)

-Summary

The purpose of this study is to demonstrate that addition of the Monocyte Width Distribution (MDW) parameter to current standard of care improves a clinician's ability to recognize sepsis in the Emergency Department, resulting in earlier decision to administer antibiotics from time of ED presentation for sepsis patients (simulated primary endpoint), with concomitant reductions in length of stay and in-hospital mortality for those patients (secondary endpoints).

Expand all sections  ·  Collapse all

+Detailed description

The objective of this study is to develop a method for identifying sepsis patients from electronic health records (EHR) based on Sepsis-2 criteria. Sepsis patients will be identified using a Sepsis Definition which includes meeting SIRS score of ≥2 within 12 hours of ED presentation and any microbial testing ordered within 24 hours of ED presentation. The patient will be enrolled if it meets the Sepsis Definition and additional EMR data elements will be extracted to complete case report form. Furthermore, objectives include to confirm the clinical validity and performance of MDW in a control population of sepsis patients where MDW is measured but not reported to physicians. This study is an observational study which will simulate the decision impact of MDW on sepsis identification and patient management

+Arms and interventions

ArmTypeInterventionsDescription
CBC-Diff Monocyte Volume Width DistributionDiagnostic Test: CBC-DIFF Monocyte Volume Width Distribution (MDW)Monocyte Volume Width Distribution (MDW) is part of the CBC with Differential
  • CBC-DIFF Monocyte Volume Width Distribution (MDW) (Diagnostic test): MDW measurement will be used to detect sepsis. Results will not be used to manage patients.

+Outcome measures

Primary outcomes

  • Potential reduction of Time to Antibiotics [12 hours after ED presentation]: Validate MDW's ability to reduce time to first antibiotics ordered by physician (decision to treat)-Simulated

Secondary outcomes

  • Performance [12 hours after ED presentation]: Validate MDW's ability to identify incidence of patients diagnosed as Sepsis vs Non-Sepsis, including SIRS and milder forms of infection (non-SIRS) meeting Sepsis EMR definition of >=2 SIRS criteria within 12 hours of ED presentation and any microbial testing collected within 24 hours of triage in the ED

Other outcomes

  • Health & Economic Benefits for Time to Antibiotics - Simulated [12 hours after ED presentation]: Determine MDW's ability to potentially reduced hospital stay using a simulated economic model
  • Health & Economic Benefits for Hospital Stay - Simulated [12 hours after ED presentation]: Determine MDW's ability to potentially reduced Hospital stay, if applicable, using a simulated economic model
  • Health & Economic Benefits for Mortality - Simulated [12 hours after ED presentation]: Determine MDW's ability to potentially reduced hospital morality, if applicable, using a simulated economic model
  • Health & Economic Benefits for ICU Stay - Simulated [12 hours after ED presentation]: Determine MDW's ability to potentially reduced ICU stay, if applicable, using a simulated economic model

+Eligibility

Sex: All, ages: 18 Years to 89 Years

Inclusion Criteria:

* All race and ethnicities
* Presenting to the emergency department with suspicion of infection
* Whose assessment includes a CBC with differential
* Meets EMR Sepsis Definition

Exclusion Criteria:

* Pregnancy
* Prisoners
* Transfers from other ED
* Previously enrolled

+Locations (1)

FacilityCityCountryStatus
Washington UniversitySt Louis, MissouriUnited States

+Investigators